Detalhe da pesquisa
1.
Demographic and socioeconomic correlates to buprenorphine access in pharmacies.
J Am Pharm Assoc (2003)
; 63(3): 751-759, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658013
2.
How protected classes in Medicare Part D influence U.S. drug sales, utilization, and price.
Health Econ
; 29(5): 608-623, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027436
3.
Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.
J Subst Use Addict Treat
; 158: 209247, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072386
4.
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine.
J Addict Med
; 18(1): 78-81, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126704
5.
Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.
Health Aff (Millwood)
; 42(7): 991-996, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406230
6.
The effect of cancer exemption in mandatory-access prescription drug monitoring programs among oncologists.
JNCI Cancer Spectr
; 7(2)2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36752533
7.
Availability of Medications for Alcohol Use Disorder Treatment in Medicare Part D, 2014-2018.
J Stud Alcohol Drugs
; 83(5): 653-661, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136435
8.
National Estimates of Mental Health Needs Among Adults With Self-Reported CKD in the United States.
Kidney Int Rep
; 7(7): 1630-1642, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812303
9.
Medicaid expansion and opioid overdose mortality among socioeconomically disadvantaged populations in the US: A difference in differences analysis.
Drug Alcohol Depend
; 233: 109381, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259679
10.
Availability of Medications for the Treatment of Alcohol Use Disorder in U.S. Counties, 2016-2019.
J Stud Alcohol Drugs
; 82(6): 689-699, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762028
11.
Association of prescription drug monitoring program laws with bedridden and missed work days.
Health Serv Res
; 56(6): 1215-1221, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409600
12.
Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
Psychiatr Serv
; 72(2): 148-155, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33267651
13.
Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.
Psychiatr Serv
; 71(1): 12-20, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31575353
14.
Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries.
Health Aff (Millwood)
; 39(2): 233-237, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011945
15.
Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
Health Serv Res
; 53(2): 671-689, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101955
16.
Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist.
JAMA Oncol
; 6(7): 1102-1103, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32379277